Intestinal Absorption of Lipids Using a Pancreatic Enzyme-Free Nutritional Supplement in Patients with Cystic Fibrosis: A Randomized, Double-Blind, Crossover Pilot Trial

Nutritional supplements for patients with exocrine pancreatic insufficiency (EPI) typically utilize pancreatic enzyme replacement therapy (PERT) which is associated with gastrointestinal side effects. We evaluated serum triglyceride levels in patients with cystic fibrosis following consumption of an...

Descripción completa

Detalles Bibliográficos
Autores principales: Barto, Tara L., Morency, Clarissa F., Schaap, Nicoline, Patel, Ami B., Monticello, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8838800/
https://www.ncbi.nlm.nih.gov/pubmed/35277038
http://dx.doi.org/10.3390/nu14030680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8838800/
https://www.ncbi.nlm.nih.gov/pubmed/35277038
http://dx.doi.org/10.3390/nu14030680

Ejemplares similares